secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quantum-Si Inc (QSI)
CIK:        0001816431
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0001140361-24-010435
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quantum-Si Q4 rev $400k, net loss $22M; full commercial launch expected by end Q1 2024
--------------------------------------------------------------------------------

- Revenue $400k in Q4 2023, $1.1M for FY2023; gross margin 45%.
- Net loss narrowed to $22.0M in Q4 ($96.0M FY) from $33.1M ($132.4M FY) prior year.
- Expects full commercial launch of Platinum instrument by end of Q1 2024; version 2 sequencing kit already shipping.
- Version 3 sequencing kit planned for release by end of Q3 2024.
- Third international distribution partner TOMY Digital Biology (Japan) added.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816431/000114036124010435/0001140361-24-010435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816431/000114036124010435/ef20022499_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-010435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer